Results 61 to 70 of about 2,709 (190)

Chromoblastomycosis: A rare fungal infection from a nonendemic region—Southern Odisha

open access: yesJournal of Dr. NTR University of Health Sciences, 2020
Chromoblastomycosis, a slowly progressing localized fungal infection confined to the skin and subcutaneous tissue, is caused by dematiaceous fungi. Dermal lesions are pleomorphic and can range from small nodules to large papillary like eruptions. Herein,
Akash Panigrahi   +2 more
doaj   +1 more source

Chromoblastomycosis: a case series from Sumba, eastern Indonesia [PDF]

open access: yes
Chromoblastomycosis is a highly neglected implantation mycosis, typically affecting agricultural workers in impoverished rural communities in (sub)tropical regions.

core   +1 more source

Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi

open access: yesMycoses, Volume 69, Issue 1, January 2026.
ABSTRACT Fungal infections are increasingly recognised as a global health challenge, responsible for millions of cases annually and substantial mortality, especially in immunocompromised individuals. Yet, the diagnosis of these infections remains notoriously difficult, often delayed by slow culture‐based methods or hindered by the high cost and ...
Anthony G. J. Medeiros   +8 more
wiley   +1 more source

Curious Facial Lesion: A Case Report of Facial Chromoblastomycosis

open access: yesClinical Dermatology Review
Chromoblastomycosis is a chronic, progressive, noncontagious, localized fungal infection of the cutaneous and subcutaneous tissues. The causative agents include dematiaceous fungi such as Fonsecaea pedrosoi, Fonsecaea compactum, Phialophora verrucosa ...
Jisna Joy, DG Vinay, BM Soumya
doaj   +1 more source

Chromoblastomycosis in Nepal: A study of 13 cases [PDF]

open access: yes, 2007
Background: Chromoblastomycosis is a chronic fungal infection caused by several pigmented fungi commonly seen in tropical and subtropical climates. Aim: To evaluate the epidemiologic, clinical and pathological characteristics of chromoblastomycosis in ...
Talwar, OP   +5 more
core   +1 more source

Research Progress in Photodynamic Therapy for Infectious Skin Diseases

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Photodynamic therapy (PDT) is a noninvasive therapeutic strategy that utilizes the synergistic interaction among a photosensitizer, light of a specific wavelength, and tissue oxygen to generate cytotoxic reactive oxygen species (ROS), thereby selectively destroying pathological tissues.
Lingzhi Xu   +5 more
wiley   +1 more source

CHROMOBLASTOMYCOSIS

open access: yesDermatologic Clinics, 1996
Chromoblastomycosis is a chronic cutaneous infection due to several varieties of pigmented fungi. Diagnosis is straightforward and based on clinical and microscopic findings. Despite the protracted course of the disease, dissemination of the infection is rare. New insights into the pathophysiology may permit a closer appreciation of the clinical course.
openaire   +2 more sources

Epidemiology and main clinical aspects of 7,740 cases of chromoblastomycosis documented in 5 different continents.

open access: yes, 2021
Epidemiology and main clinical aspects of 7,740 cases of chromoblastomycosis documented in 5 different continents.
Conceição de Maria Pedrozo e Silva de Azevedo (8087849)   +7 more
core   +1 more source

Rare Presentation of Kaposi Sarcoma Mimicking Madura Foot: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Kaposi sarcoma (KS) is a low‐grade angioproliferative tumor primarily associated with HIV but also seen in immunocompetent individuals. Its presentation can mimic infectious diseases such as Madura foot (mycetoma), a chronic granulomatous infection endemic to tropical regions.
Jeminah Nyeenya Nakatudde   +2 more
wiley   +1 more source

A Rapid Assessment Approach for Skin Stratum‐Targeted Drug Delivery Systems Using Mass Spectrometry Imaging and Spatial Clustering

open access: yesSmall Science, Volume 5, Issue 8, August 2025.
This study presents a novel method for rapidly evaluating dermal drug delivery systems (DDSs). Using mass spectrometry imaging and automated data analysis, it visualizes drug distribution within skin layers in under 10 min. Tested with three nanoscale DDSs for antifungal terbinafine, the approach reveals key differences in drug permeation depth and ...
Ravit Yakobi Arancibia   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy